Home＜ News & Events

News & Events

News Events Media Attention Partner News

 

2023.08
14

Exploring the Dark Horse in the ADC CDMO Field：TOT Biopharm's (01875.HK) continuous performance growth attracted attention
2023.07
28

A Biotech decided to fully turn into CDMO
2023.03
27

What we can learn from the success of TOT BIOPHARM transformed into a CDMO company ?
2023.03
24

On a journey to recovery, TOT BIOPHARM-B (01875.HK) establishes core competitive advantages to capture the lead of the industry
2023.03
20

Revenue increased nearly fivefold and cash flows from operating activities turned positive, revealed TOT BIOPHARM-B (01875) achieved remarkable results in strategic transformation
2023.03
20

ADC enjoys a promising future! TOT BIOPHARM's differentiated CDMO strategy achieved initially, cash flow turns positive for the first time!